| 000 | 04899nam a22004455i 4500 | ||
|---|---|---|---|
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 999 |
_c329583 _d329583 _x1 |
||
| 001 | 329583 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102114425.0 | ||
| 008 | 201209s2020 si | s |||| 0|eng d | ||
| 020 | _a9789811562556 | ||
| 024 | 7 |
_a10.1007/978-981-15-6255-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aR857.N34 _b2020 EB |
|
| 245 | 0 | 0 |
_aNano Medicine and Nano Safety. _bRecent Trends and Clinical Evidences _cedited by Malay K. Das, Yashwant V. Pathak |
| 250 | _aFirst edition 2020 | ||
| 264 | 1 |
_aSingapore _bSpringer Singapore : _bImprint: Springer _c2020. |
|
| 300 |
_a1 recurso en línea (XVI, 635 páginas) _b57 ilustraciones, 34 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (SpringerNature-11642) | |
| 490 | 0 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | |
| 505 | 0 | _aPart A: Applications of Nano Biotechnology in the development of Nano Medicine -- Chapter 1. Nanobiotechnology and its application in Nanomedicine: An Overview -- Chapter 2. Nanobiotechnology for therapeutic targeting of circulating tumor cells in the blood -- Chapter 3. Application of Nanobiotechnology in clinical diagnosis -- Chapter 4. Anti-diabetic Nano formulation from herbal source -- Chapter 5. Nanomaterials for alternative antibiotic therapy -- Part B: Nano Medicine: concept, development, clinical applications and evidences -- Chapter 6. Nano medicines and Nano drug delivery systems: trends and perspectives -- Chapter 7. Nano medicines in drug delivery from synthetic/natural sources to their clinical applications -- Chapter 8. Transdermal Nanomedicines for Reduction of Dose And Site-Specific Drug Delivery -- Chapter 9. Multifunctional mesoporous silica nanoparticles for biomedical applications -- Chapter 10. Advances in pulmonary Nano medicine for therapeutic management of respiratory diseases -- Chapter 11. Nanoemulsion Delivery of Herbal Products: Prospects and Challenges -- Chapter 12. Stimuli-responsive polymers for cancer Nano medicines -- Chapter 13. Carbohydrate-Derived Tailorable Interfaces: Recent Advances and Applications -- Chapter 14. Multifunctional Nano scale particles for theranostic application in healthcare -- Chapter 15. Ligand nanoparticle conjugation approach for targeted cancer chemotherapy -- Chapter 16. Tunable Biopolymeric Drug Carrier Nanovehicles and Their Safety -- Chapter 17. Nano medicine for challenging solid tumors: Recent trends and future ahead -- Part C: Regulatory, safety and marketing aspects of Nano Medicine -- Chapter 18. Recent trends for Nano medicine safety -- Chapter 19. Nano toxicity and risk assessment of Nano medicines -- Chapter 20. Clinical toxicity of Nano medicines -- Chapter 21. Nano Medicine: Risk, Regulation, Safety and Public Health -- Chapter 22. New deliveries and nanomedicines: Commercial aspects and business perspectives -- Chapter 23. Global growth of Nano medicines and what role it will play for economically weak countries. | |
| 520 | 3 | _aThis book reviews the application of Nanobiotechnology in the development of Nanomedicine, while also discussing the latest trends and challenges in the clinical translation of Nanomedicine. Nanomedicine refers to the application of Nanotechnology to medicine and holds tremendous potential for achieving improved efficiency, bioavailability, dose response, personalized medicine and enhanced safety as compared to conventional medicines. The book first introduces readers to the basic concepts of Nanomedicine, and to technological advances in and applications of Nanotechnology in treatment, diagnosis, monitoring, and drug delivery. In turn, it reviews the current status of multi-functionalization strategies for using Nanoparticles in the targeted delivery of therapeutic agents. The book's third and final section focuses on the regulatory and safety challenges posed by Nanomedicine, including industry and regulatory agencies' efforts to address them. | |
| 988 | _aSpringer_BiomedLife_dic2020 | ||
| 650 | 7 |
_2embne _aNanomedicina _9445593 |
|
| 700 | 1 |
_aDas, Malay K _eeditor literario _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aPathak, Yashwant V _eeditor literario _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811562549 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811562563 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811562570 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-6255-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2021 _dz _ea _zSI |
||